A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase ???/??? Clinical Study to Evaluate the Efficacy and Safety of CMS-D001 Tablets in Adult Patients With Moderate to Severe Plaque Psoriasis
Latest Information Update: 03 Mar 2026
At a glance
- Drugs CMS D001 (Primary)
- Indications Plaque psoriasis
- Focus Registrational; Therapeutic Use
- Sponsors Dermavon
Most Recent Events
- 03 Mar 2026 New trial record